`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`AMNEAL PHARMACEUTICALS LLC AND
`AMNEAL PHARMACEUTICALS OF NEW YORK, LLC,
`Petitioners,
`
`v.
`
`ALMIRALL, LLC
`Patent Owner.
`
`
`Case IPR2018-00608
`Patent No. 9,161,926 B2
`
`PATENT OWNER’S OBJECTIONS TO REPLY EVIDENCE
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2018-00608
`Patent Owner’s Objections to Reply Evidence
`
`
`
`
`Pursuant to 37 C.F.R. § 42.64, Patent Owner Almirall, LLC (“Almirall”)
`
`hereby objects to the admissibility of evidence Petitioners Amneal Pharmaceuticals
`
`LLC and Amneal Pharmaceuticals of New York, LLC (collectively, “Amneal”)
`
`submitted with their Reply to Patent Owner’s Response (Paper 29):
`
`1.
`
`Almirall objects to Exhibit 1035 as lacking authentication under FRE
`
`901. Exhibit 1035 purports to be a publication from 2012 but there is no evidence
`
`establishing that it contains true and correct content. Accordingly, Amneal has not
`
`provided evidence sufficient to support a finding that Exhibit 1035 “is what
`
`[Amneal] claims it is.” See FRE 901. Almirall further objects to Exhibit 1035 as
`
`irrelevant under FRE 401 and 402. Exhibit 1035 purports to be a publication from
`
`December 2012. There is no evidence that Exhibit 2012 is a prior art publication
`
`available to the public before November 20, 2012, the earliest date to which U.S.
`
`patent No. 9,161,926 claims priority. See Ex. 1001 at cover, 1:8–12. Almirall
`
`further objects to Exhibit 1035 as inadmissible hearsay under FRE 801 and 802.
`
`Amneal failed to examine Dr. Harper, a purported author of this document,
`
`regarding Exhibit 1035. See generally Ex. 1049 (transcript of March 11, 2019
`
`deposition of Dr. Harper).
`
`2.
`
`Almirall objects to Exhibit 1036 as irrelevant under FRE 401 and 402
`
`because Amneal did not rely upon or discuss this exhibit in its Reply. This exhibit
`
`1
`
`
`
`IPR2018-00608
`Patent Owner’s Objections to Reply Evidence
`
`is only cited in the Second Declaration of Dr. Gilmore. Ex. 1034 ¶ 21. Any use of
`
`this exhibit would be improper incorporation by reference under 37 C.F.R.
`
`§ 42.6(a)(3).
`
`3.
`
`Almirall objects to Exhibit 1037 as irrelevant under FRE 401 and 402
`
`because Amneal did not rely upon or discuss this exhibit in its Reply. This exhibit
`
`is only cited in the Second Declaration of Dr. Gilmore. Ex. 1034 ¶ 20. Any use of
`
`this exhibit would be improper incorporation by reference under 37 C.F.R.
`
`§ 42.6(a)(3).
`
`4.
`
`Almirall objects to Exhibit 1038 as irrelevant under FRE 401 and 402
`
`because Amneal did not rely upon or discuss this exhibit in its Reply. This exhibit
`
`is only cited in the Second Declaration of Dr. Gilmore. Ex. 1034 ¶ 20. Any use of
`
`this exhibit would be improper incorporation by reference under 37 C.F.R.
`
`§ 42.6(a)(3).
`
`5.
`
`Almirall objects to Exhibit 1039 as irrelevant under FRE 401 and 402
`
`because Amneal did not rely upon or discuss this exhibit in its Reply. This exhibit
`
`is only cited in the Second Declaration of Dr. Gilmore. Ex. 1034 ¶ 20. Any use of
`
`this exhibit would be improper incorporation by reference under 37 C.F.R.
`
`§ 42.6(a)(3).
`
`6.
`
`Almirall objects to Exhibit 1040 as irrelevant under FRE 401 and 402
`
`because Amneal did not rely upon or discuss this exhibit in its Reply. This exhibit
`
`2
`
`
`
`IPR2018-00608
`Patent Owner’s Objections to Reply Evidence
`
`is only cited in the Second Declaration of Dr. Gilmore. Ex. 1034 ¶ 20. Any use of
`
`this exhibit would be improper incorporation by reference under 37 C.F.R.
`
`§ 42.6(a)(3).
`
`7.
`
`Almirall objects to Exhibit 1041 as irrelevant under FRE 401 and 402
`
`because it has no tendency to make any fact of consequence in determining this
`
`action more or less probable than it would be without this exhibit. Almirall further
`
`objects to Exhibit 1041 as lacking authentication under FRE 901. Exhibit 1041
`
`purports to be a printout or partial printout of a webpage but there is no evidence
`
`establishing that it contains true and correct content. Accordingly, Amneal has not
`
`provided evidence sufficient to support a finding that Exhibit 1041 “is what
`
`[Amneal] claims it is.” See FRE 901. Almirall further objects to Exhibit 1041 as
`
`inadmissible hearsay under FRE 801 and 802. Amneal has provided no evidence
`
`of the truth of the assertions in Exhibit 1041.
`
`8.
`
`Almirall objects to Exhibit 1042 as irrelevant under FRE 401 and 402
`
`because it has no tendency to make any fact of consequence in determining this
`
`action more or less probable than it would be without this exhibit. Almirall further
`
`objects to Exhibit 1042 as lacking authentication under FRE 901. Exhibit 1042
`
`purports to be a printout or partial printout of a webpage but there is no evidence
`
`establishing that it contains true and correct content. Accordingly, Amneal has not
`
`provided evidence sufficient to support a finding that Exhibit 1042 “is what
`
`3
`
`
`
`IPR2018-00608
`Patent Owner’s Objections to Reply Evidence
`
`[Amneal] claims it is.” See FRE 901. Almirall further objects to Exhibit 1042 as
`
`inadmissible hearsay under FRE 801 and 802. Amneal has provided no evidence
`
`of the truth of the assertions in Exhibit 1042.
`
`9.
`
`Almirall objects to Exhibit 1043 as irrelevant under FRE 401 and 402
`
`because it has no tendency to make any fact of consequence in determining this
`
`action more or less probable than it would be without this exhibit. Almirall further
`
`objects to Exhibit 1043 as lacking authentication under FRE 901. Exhibit 1043
`
`purports to be a printout or partial printout of a webpage but there is no evidence
`
`establishing that it contains true and correct content. Accordingly, Amneal has not
`
`provided evidence sufficient to support a finding that Exhibit 1043 “is what
`
`[Amneal] claims it is.” See FRE 901. Almirall further objects to Exhibit 1043 as
`
`inadmissible hearsay under FRE 801 and 802. Amneal has provided no evidence
`
`of the truth of the assertions in Exhibit 1043.
`
`10. Almirall objects to Exhibit 1044 as irrelevant under FRE 401 and 402
`
`because it has no tendency to make any fact of consequence in determining this
`
`action more or less probable than it would be without this exhibit. Almirall further
`
`objects to Exhibit 1044 as lacking authentication under FRE 901. Exhibit 1044
`
`purports to be a printout or partial printout of a webpage but there is no evidence
`
`establishing that it contains true and correct content. Accordingly, Amneal has not
`
`provided evidence sufficient to support a finding that Exhibit 1044 “is what
`
`4
`
`
`
`IPR2018-00608
`Patent Owner’s Objections to Reply Evidence
`
`[Amneal] claims it is.” See FRE 901. Almirall further objects to Exhibit 1044 as
`
`inadmissible hearsay under FRE 801 and 802. Amneal has provided no evidence
`
`of the truth of the assertions in Exhibit 1044.
`
`11. Almirall objects to Exhibit 1045 as irrelevant under FRE 401 and 402
`
`because it has no tendency to make any fact of consequence in determining this
`
`action more or less probable than it would be without this exhibit. Almirall further
`
`objects to Exhibit 1045 as lacking authentication under FRE 901. Exhibit 1045
`
`purports to be a printout or partial printout of a webpage but there is no evidence
`
`establishing that it contains true and correct content. Accordingly, Amneal has not
`
`provided evidence sufficient to support a finding that Exhibit 1045 “is what
`
`[Amneal] claims it is.” See FRE 901. Almirall further objects to Exhibit 1045 as
`
`inadmissible hearsay under FRE 801 and 802. Amneal has provided no evidence
`
`of the truth of the assertions in Exhibit 1045.
`
`12. Almirall objects to Exhibit 1046 as irrelevant under FRE 401 and 402
`
`because it has no tendency to make any fact of consequence in determining this
`
`action more or less probable than it would be without this exhibit. Almirall further
`
`objects to Exhibit 1046 as lacking authentication under FRE 901. Exhibit 1046
`
`purports to be a printout or partial printout of a webpage but there is no evidence
`
`establishing that it contains true and correct content. Accordingly, Amneal has not
`
`provided evidence sufficient to support a finding that Exhibit 1046 “is what
`
`5
`
`
`
`IPR2018-00608
`Patent Owner’s Objections to Reply Evidence
`
`[Amneal] claims it is.” See FRE 901. Almirall further objects to Exhibit 1046 as
`
`inadmissible hearsay under FRE 801 and 802. Amneal has provided no evidence
`
`of the truth of the assertions in Exhibit 1046.
`
`13. Almirall objects to Exhibit 1047 as irrelevant under FRE 401 and 402
`
`because it has no tendency to make any fact of consequence in determining this
`
`action more or less probable than it would be without this exhibit. Almirall further
`
`objects to Exhibit 1047 as lacking authentication under FRE 901. Exhibit 1047
`
`purports to be a printout or partial printout of a webpage but there is no evidence
`
`establishing that it contains true and correct content. Accordingly, Amneal has not
`
`provided evidence sufficient to support a finding that Exhibit 1047 “is what
`
`[Amneal] claims it is.” See FRE 901. Almirall further objects to Exhibit 1047 as
`
`inadmissible hearsay under FRE 801 and 802. Amneal has provided no evidence
`
`of the truth of the assertions in Exhibit 1047.
`
`14. Almirall objects to Exhibit 1048 as irrelevant under FRE 401 and 402
`
`because Amneal did not cite, rely upon, or discuss this exhibit in its Reply or in
`
`any expert declaration. Almirall also objects to Exhibit 1048 as irrelevant under
`
`FRE 401 and 402 because it has no tendency to make any fact of consequence in
`
`determining this action more or less probable than it would be without this exhibit.
`
`Almirall further objects to Exhibit 1048 as lacking authentication under FRE 901.
`
`Exhibit 1048 purports to be a printout or partial printout of a webpage but there is
`
`6
`
`
`
`IPR2018-00608
`Patent Owner’s Objections to Reply Evidence
`
`no evidence establishing that it contains true and correct content. Accordingly,
`
`Amneal has not provided evidence sufficient to support a finding that Exhibit 1048
`
`“is what [Amneal] claims it is.” See FRE 901. Almirall further objects to Exhibit
`
`1048 as inadmissible hearsay under FRE 801 and 802. Amneal has provided no
`
`evidence of the truth of the assertions in Exhibit 1048.
`
`15. Almirall objects to Exhibit 1053 as irrelevant under FRE 401 and 402
`
`because Amneal did not substantively discuss this exhibit in its Reply. Any use of
`
`this exhibit would be improper incorporation by reference under 37 C.F.R.
`
`§ 42.6(a)(3). Almirall further objects to Exhibit 1053 as lacking authentication
`
`under FRE 901. Exhibit 1053 purports to be an article published in 2014, and
`
`Amneal’s expert Dr. Michniak-Kohn describes it as describing the regulatory
`
`status of DGME in 2012. See Ex. 1050 ¶ 31. There is no evidence establishing
`
`that it contains true and correct content. Accordingly, Amneal has not provided
`
`evidence sufficient to support a finding that Exhibit 1053 “is what [Amneal] claims
`
`it is. See FRE 901. Almirall further objects to Exhibit 1053 as inadmissible
`
`hearsay under FRE 801 and 802. Amneal has provided no evidence of the truth of
`
`the assertions in Exhibit 1053.
`
`16. Almirall objects to Exhibit 1054 as lacking authentication under FRE
`
`901. Exhibit 1054 appears to be a portion of a printout of a webpage. There is no
`
`evidence establishing that it contains true and correct content. Accordingly,
`
`7
`
`
`
`IPR2018-00608
`Patent Owner’s Objections to Reply Evidence
`
`Amneal has not provided evidence sufficient to support a finding that Exhibit 1054
`
`“is what [Amneal] claims it is. See FRE 901. Almirall further objects to Exhibit
`
`1054 as irrelevant under FRE 401 and 402. If the content is taken as true, the
`
`information on the printout relates to 2019. There is no evidence that Exhibit 1054
`
`is a prior art publication that is available to the public. Therefore, Exhibit 1054 is
`
`inadmissible as not relevant.
`
`17. Almirall objects to Exhibit 1055 as lacking authentication under FRE
`
`901. Exhibit 1054 appears to be a portion of a printout of a webpage. There is no
`
`evidence establishing that it contains true and correct content. Accordingly,
`
`Amneal has not provided evidence sufficient to support a finding that Exhibit 1055
`
`“is what [Amneal] claims it is. See FRE 901. Almirall further objects to Exhibit
`
`1055 as irrelevant under FRE 401 and 402. If the content is taken as true, the
`
`information on the printout relates to 2019. There is no evidence that Exhibit 1055
`
`is a prior art publication that is available to the public. Therefore, Exhibit 1055 is
`
`inadmissible as not relevant.
`
`18. Almirall objects to Exhibit 1059 as irrelevant under FRE 401 and 402
`
`because Amneal did not rely upon or discuss this exhibit in its Reply. Although
`
`Almirall’s Reply cited to Exhibit 1059 in two places (Paper 29 at 9, 16), both
`
`citations are clearly intended to be to Exhibit 1058, as from context both purport to
`
`be citations to Dr. Klibanov’s deposition transcript (Ex. 1058) and include page
`
`8
`
`
`
`IPR2018-00608
`Patent Owner’s Objections to Reply Evidence
`
`and line numbers as found in a deposition transcript, with no correlation to the
`
`document filed as AMN1059. This exhibit is only cited with a pinpoint citation
`
`that corresponds to the document filed as AMN1059 in the Second Declaration of
`
`Dr. Michniak-Kohn (Ex. 1050 ¶ 65). Accordingly, any use of this exhibit would
`
`be improper incorporation by reference under 37 C.F.R. § 42.6(a)(3).
`
`19. Any paragraph of Exhibit 1034 and/or Exhibit 1050 that relies on any
`
`of the exhibits identified above is objected to for the same reason(s) as Almirall’s
`
`objection(s) to the underlying exhibit.
`
`These objections are made and filed within five business days of March 18,
`
`2019, the date of service of Petitioners’ Reply. 37 C.F.R. § 42.64(b)(1).
`
`
`
`Dated: March 25, 2019
`
`
`
`
`
`
`Respectfully submitted,
`
`FENWICK & WEST LLP
`
`By:/James S. Trainor/
`James S. Trainor (Reg. No. 52,297)
`
`
`
`Attorneys for Patent Owner
`Almirall, LLC
`
`
`9
`
`
`
`IPR2018-00608
`Patent Owner’s Objections to Reply Evidence
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on March 25, 2019, the
`
`foregoing PATENT OWNER’S OBJECTIONS TO REPLY EVIDENCE was served by
`
`electronic mail on the following counsel of record for petitioner:
`
`Dennies Varughese (dvarughe-PTAB@skgf.com)
`Adam C. LaRock (alarock-PTAB@skgf.com)
`PTAB@skgf.com
`Sterne, Kessler, Goldstein & Fox
`1100 New York Avenue, NW, Suite 600
`Washington, DC 20005
`
`
`
`
`
`
`
`
`
`Dated: March 25, 2019
`
`
`
`
`Respectfully submitted,
`
`FENWICK & WEST LLP
`
`By:/James S. Trainor/
`James S. Trainor (Reg. No. 52,297)
`
`
`
`Attorneys for Patent Owner
`Almirall, LLC
`
`
`
`
`
`